83 results
Page 3 of 5
424B5
27gi0rmawusl0jxlctrt
7 Jan 20
Prospectus supplement for primary offering
4:19pm
S-3ASR
EX-4.3
15p3pup 9t
7 Jan 20
Automatic shelf registration
4:01pm
S-3ASR
EX-4.4
p4keglud1k1bk
7 Jan 20
Automatic shelf registration
4:01pm
8-K
EX-10.1
0h15o tpt
7 Oct 19
Departure of Directors or Certain Officers
4:06pm
POS AM
EX-1.2
ztyijx36dt39bu2 d5
4 Oct 19
Prospectus update (post-effective amendment)
4:59pm
POS AM
jlypn mgnvldeuhc9
4 Oct 19
Prospectus update (post-effective amendment)
4:59pm
8-K
EX-4.1
8nc4i wj0qr
16 Sep 19
Apellis Pharmaceuticals Announces Closing of Offering of Convertible Senior Notes
5:17pm
8-K
EX-10.1
9uf9e5 y02lo0q
16 Sep 19
Apellis Pharmaceuticals Announces Closing of Offering of Convertible Senior Notes
5:17pm
424B5
gkqutg56in3zxcusjvd
7 Mar 19
Prospectus supplement for primary offering
4:28pm
8-K
EX-1.1
z2621bpsih2ee
7 Mar 19
Apellis Pharmaceuticals Announces Pricing of Public Offering of Common Stock
4:15pm
424B5
v2iz0b31tu v1
6 Mar 19
Prospectus supplement for primary offering
4:07pm
POS AM
p2w251jl1qo vr
26 Feb 19
Prospectus update (post-effective amendment)
4:47pm
POSASR
9iz0r6tqd9o0xxz
26 Feb 19
Automatic shelf registration (post-effective amendment)
4:05pm